Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-06-22 08:14 am Sale | 2021-06-15 | 13D | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL LLC | 0 0.000% | -1,490 (Position Closed) | Filing History |
| 2020-09-16 4:56 pm Purchase | 2020-09-14 | 13D | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL LLC | 1,490 97.900% | 138 (+10.20%) | Filing History |
| 2020-08-20 4:50 pm Purchase | 2020-08-13 | 13D | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL LLC | 1,352 97.700% | 2 (+0.12%) | Filing History |
| 2020-04-01 4:22 pm Purchase | 2020-03-25 | 13D | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL LLC | 1,350 98.800% | 141 (+11.67%) | Filing History |
| 2020-02-10 3:17 pm Purchase | 2019-12-31 | 13G | ReShape Lifesciences Inc. RSLS | CVI Investments, Inc. | 1 2.900% | 1 (New Position) | Filing History |
| 2020-01-21 2:28 pm Purchase | 2019-12-31 | 13G | ReShape Lifesciences Inc. RSLS | SABBY MANAGEMENT, LLC | 0 11.000% | 0 (New Position) | Filing History |